An altered Th1/Th2 and pro-inflammatory cytokine profile in patients with end-stage renal disease detected by suspension array technology

Renal Failure

Volumn 31, Issue 1, 2009, Pages 1-5

  Sui, Weiguo ^a   Tan, Jiefeng ^b   Guo, Junjun ^a   Du, Guizhi ^c   Dai, Yong ^a  

^a The 181th Hospital of PLA   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Cytokine; ESRD; Pro inflammatory; Suspension array technology; Th1 Th2

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; LYMPHOTOXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TH1 CELL; TH2 CELL;

ADULT; CYTOKINES; FEMALE; HUMANS; IMMUNOASSAY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TH1 CELLS; TH2 CELLS;

EID: 61649089488     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802516449     Document Type: Article

References (27)

1. U.S. Renal Data System. USRDS 2007 Annual Data Report. Bethesda, Md.: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2007. Available at: http://www.usrds.org/2007/Atlas-07.exe, http://www.usrds.org/2007/pres/GILBERTSON-ASN-PRESENTATION-11-2-07-tmp.swf
2. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16: 3736-3741.
3. Sayarlioglu H, Erkoc R, Demir C, et al. Nutritional status and immune functions in maintenance hemodialysis patients. Mediators Inflamm. 2006;20264:1-4.
4. Alvarez-Lara MA, Carracedo J, Ramírez R, et al. The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant. 2004;19:3084-3090.
5. Libetta C, Rampino T, Dal Canton A. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis. 2001;38:286-295.
6. Yokoyama T, Nitta K, Futatsuyama K, et al. Identification of T helper cell subsets in continuous ambulatory peritoneal dialysis patients. Nephron. 2001;89:215-218.
7. Nitta K, Akiba T, Kawashima A, et al. Characterization of TH1/TH2 profile in uremic patients. Nephron. 2002;91:492-495.
8. Heijmans-Antonissen C, Wesseldijk F, Munnikes RJ, et al. Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm.2006; 28398:1-8.
9. Hsing CH, Hsu CC, Chen WY, et al. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant. 2007;22:2230-2238.
10. Rysz J, Banach M, Cialkowska-Rysz A, et al. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Cell Mol Immunol. 2006;3:151-154.
11. Engelberts I, Francot GJ, Leunissen KM, et al. Effect of hemodialysis on peripheral blood monocyte tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion in vitro. Nephron. 1994;66:396-403.
12. Herbelin A, Nguyen AT, Urena P, Descamps-Latscha B. Induction of cytokines by dialysis membranes in normal whole blood: A new in vitro assay for evaluating membrane biocompatibility. Blood Purif. 1992;10:40-52.
13. Niwa T, Miyazaki T, Sato M, et al. Interleukin 8 and biocompatibility of dialysis membranes. Am J Nephrol. 1995;15:181-185.
14. Chen R, Lowe L, Wilson JD, et al. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin Chem. 1999;45:1693-1694.
15. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243:243-255.
16. Kellar KL, Kalwar RR, Dubois KA, et al. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry. 2001;45:27-36.
17. Kellar KL, Iannone MA. Multiplexed microsphere-based flow cytometric assays. Exp Hematol. 2002;30:1227-1237.
18. Moser B, Roth G, Brunner M, et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: A comparative evaluation between nondialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun. 2003;308:581-585.
19. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
20. Goldsby RA, Kindt TJ, Kuby J, Osborne BA. Immunology. 5th ed. New York: W. H. Freeman. 2002;228-291.
21. Tarakcioglu M, Erbagci AB, Usalan C, et al. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators Inflamm. 2003;12:15-19.
22. Kaliński P, Smits HH, Schuitemaker JH, et al. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J Immunol. 2000;165:1877-1881.
23. Timoshanko JR, Kitching AR, Iwakura Y, et al. Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am J Pathol. 2004;164:1967-1977.
24. Schaefer RM, Paczek L, Heidland A. Cytokine production by monocytes during haemodialysis. Nephrol Dial Transplant. 1991;6 (Suppl. 2):14-17.
25. Rysz J, Potargowicz E, Banach M, et al. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment. Arch Immunol Ther Exp (Warsz). 2006;54:347-355.
26. Banach M, Drozdz J, Okonski P, Rysz J. Immunological aspects of the statins' function in patients with heart failure: A report from the Annual Conference of ESC - Heart Failure 2005. Cell Mol Immunol. 2005;2:433-437.
27. Rysz J, Bartnicki P, Stolarek RA. Erythropoietin therapy in chronic renal failure patients prior to hemodialysis. Arch Med Sci. 2005;1:55-58.